Nuclear Export of the NF-κB Inhibitor IκBα Is Required for Proper B Cell and Secondary Lymphoid Tissue Formation

Immunity

Volumn 34, Issue 2, 2011, Pages 188-200

  Wuerzberger Davis, Shelly M ^a   Chen, Yuhong ^b   Yang, David T ^c   Kearns, Jeffrey D ^d   Bates, Paul W ^a,h   Lynch, Candace ^d   Ladell, Nicholas C ^a   Yu, Mei ^b,e   Podd, Andrew ^b,f   Zeng, Hu ^b,e   Huang, Tony T ^g   Wen, Renren ^b   Hoffmann, Alexander ^d   Wang, Demin ^b,e,f   Miyamoto, Shigeki ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NANJING UNIVERSITY   (China)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g NEW YORK UNIVERSITY   (United States)

^h UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P100; TRANSCRIPTION FACTOR RELB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; GENE INDUCTION; GENE TARGETING; INTRACELLULAR TRANSPORT; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; B-LYMPHOCYTES; CELL DEATH; CELL DIVISION; GENE EXPRESSION REGULATION; GERM-LINE MUTATION; I-KAPPA B KINASE; I-KAPPA B PROTEINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPH NODES; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NF-KAPPA B; NUCLEAR EXPORT SIGNALS; ORGAN SIZE; PEYER'S PATCHES; PROTO-ONCOGENE PROTEINS C-REL; SPLEEN; TRANSCRIPTION, GENETIC;

EID: 79951768852     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.01.014     Document Type: Article

References (52)

1. Baeuerle P.A., Baltimore D. I κ B: A specific inhibitor of the NF-κ B transcription factor. Science 1988, 242:540-546.
2. Banks T.A., Rouse B.T., Kerley M.K., Blair P.J., Godfrey V.L., Kuklin N.A., Bouley D.M., Thomas J., Kanangat S., Mucenski M.L. Lymphotoxin-α-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 1995, 155:1685-1693.
3. Carlotti F., Dower S.K., Qwarnstrom E.E. Dynamic shuttling of nuclear factor κ B between the nucleus and cytoplasm as a consequence of inhibitor dissociation. J. Biol. Chem. 2000, 275:41028-41034.
4. Castro I., Wright J.A., Damdinsuren B., Hoek K.L., Carlesso G., Shinners N.P., Gerstein R.M., Woodland R.T., Sen R., Khan W.N. B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2. J. Immunol. 2009, 182:7729-7737.
5. Chen Y., Yu M., Podd A., Wen R., Chrzanowska-Wodnicka M., White G.C., Wang D. A critical role of Rap1b in B-cell trafficking and marginal zone B-cell development. Blood 2008, 111:4627-4636.
6. Chu C.T., Plowey E.D., Wang Y., Patel V., Jordan-Sciutto K.L. Location, location, location: Altered transcription factor trafficking in neurodegeneration. J. Neuropathol. Exp. Neurol. 2007, 66:873-883.
7. De Togni P., Goellner J., Ruddle N.H., Streeter P.R., Fick A., Mariathasan S., Smith S.C., Carlson R., Shornick L.P., Strauss-Schoenberger J., et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264:703-707.
8. Deenick E.K., Elford A.R., Pellegrini M., Hall H., Mak T.W., Ohashi P.S. c-Rel but not NF-kappaB1 is important for T regulatory cell development. Eur. J. Immunol. 2010, 40:677-681.
9. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., Daro E., Smith J., Tometsko M.E., Maliszewski C.R., et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999, 13:2412-2424.
10. Drayton D.L., Liao S., Mounzer R.H., Ruddle N.H. Lymphoid organ development: From ontogeny to neogenesis. Nat. Immunol. 2006, 7:344-353.
11. Fagarasan S., Watanabe N., Honjo T. Generation, expansion, migration and activation of mouse B1 cells. Immunol. Rev. 2000, 176:205-215.
12. Ferch U., zum Büschenfelde C.M., Gewies A., Wegener E., Rauser S., Peschel C., Krappmann D., Ruland J. MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit. Nat. Immunol. 2007, 8:984-991.
13. Ghosh S., Hayden M.S. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 2008, 8:837-848.
14. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl):S81-S96.
15. Grumont R.J., Gerondakis S. The subunit composition of NF-κ B complexes changes during B-cell development. Cell Growth Differ. 1994, 5:1321-1331.
16. Hardy R.R., Hayakawa K. B cell development pathways. Annu. Rev. Immunol. 2001, 19:595-621.
17. Harhaj E.W., Sun S.C. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol. Cell. Biol. 1999, 19:7088-7095.
18. Hoffmann A., Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 2006, 210:171-186.
19. Hori S. c-Rel: A pioneer in directing regulatory T-cell lineage commitment?. Eur. J. Immunol. 2010, 40:664-667.
20. Huang T.T., Kudo N., Yoshida M., Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc. Natl. Acad. Sci. USA 2000, 97:1014-1019.
21. Huxford T., Huang D.B., Malek S., Ghosh G. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 1998, 95:759-770.
22. Inoue J., Kerr L.D., Ransone L.J., Bengal E., Hunter T., Verma I.M. c-rel activates but v-rel suppresses transcription from κ B sites. Proc. Natl. Acad. Sci. USA 1991, 88:3715-3719.
23. Isomura I., Palmer S., Grumont R.J., Bunting K., Hoyne G., Wilkinson N., Banerjee A., Proietto A., Gugasyan R., Wu L., et al. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 2009, 206:3001-3014.
24. Johnson C., Van Antwerp D., Hope T.J. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. EMBO J. 1999, 18:6682-6693.
25. Kelsall B. Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages. Mucosal Immunol. 2008, 1:460-469.
26. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
27. Koni P.A., Sacca R., Lawton P., Browning J.L., Ruddle N.H., Flavell R.A. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 1997, 6:491-500.
28. Köntgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995, 9:1965-1977.
29. Lakso M., Pichel J.G., Gorman J.R., Sauer B., Okamoto Y., Lee E., Alt F.W., Westphal H. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 1996, 93:5860-5865.
30. Long M., Park S.G., Strickland I., Hayden M.S., Ghosh S. Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 2009, 31:921-931.
31. Malek S., Chen Y., Huxford T., Ghosh G. IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells. J. Biol. Chem. 2001, 276:45225-45235.
32. Nosaka T., van Deursen J.M., Tripp R.A., Thierfelder W.E., Witthuhn B.A., McMickle A.P., Doherty P.C., Grosveld G.C., Ihle J.N. Defective lymphoid development in mice lacking Jak3. Science 1995, 270:800-802.
33. O'Connor S., Shumway S.D., Amanna I.J., Hayes C.E., Miyamoto S. Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. Mol. Cell. Biol. 2004, 24:4895-4908.
34. O'Connor S., Shumway S., Miyamoto S. Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival. Mol. Cancer Res. 2005, 3:42-49.
35. Oliver A.M., Martin F., Gartland G.L., Carter R.H., Kearney J.F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 1997, 27:2366-2374.
36. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007, 8:49-62.
37. Piao J.H., Yoshida H., Yeh W.C., Doi T., Xue X., Yagita H., Okumura K., Nakano H. TNF receptor-associated factor 2-dependent canonical pathway is crucial for the development of Peyer's patches. J. Immunol. 2007, 178:2272-2277.
38. Pohl T., Gugasyan R., Grumont R.J., Strasser A., Metcalf D., Tarlinton D., Sha W., Baltimore D., Gerondakis S. The combined absence of NF-κ B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc. Natl. Acad. Sci. USA 2002, 99:4514-4519.
39. Ruan Q., Kameswaran V., Tone Y., Li L., Liou H.C., Greene M.I., Tone M., Chen Y.H. Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 2009, 31:932-940.
40. Sen R. Control of B lymphocyte apoptosis by the transcription factor NF-kappaB. Immunity 2006, 25:871-883.
41. Stadanlick J.E., Kaileh M., Karnell F.G., Scholz J.L., Miller J.P., Quinn W.J., Brezski R.J., Treml L.S., Jordan K.A., Monroe J.G., et al. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat. Immunol. 2008, 9:1379-1387.
42. Tam W.F., Lee L.H., Davis L., Sen R. Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export. Mol. Cell. Biol. 2000, 20:2269-2284.
43. Tam W.F., Wang W., Sen R. Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes. Mol. Cell. Biol. 2001, 21:4837-4846.
44. Terry L.J., Shows E.B., Wente S.R. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 2007, 318:1412-1416.
45. Thomis D.C., Gurniak C.B., Tivol E., Sharpe A.H., Berg L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 1995, 270:794-797.
46. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
47. Vang K.B., Yang J., Pagán A.J., Li L.X., Wang J., Green J.M., Beg A.A., Farrar M.A. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. J. Immunol. 2010, 184:4074-4077.
48. Visekruna A., Huber M., Hellhund A., Bothur E., Reinhard K., Bollig N., Schmidt N., Joeris T., Lohoff M., Steinhoff U. c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur. J. Immunol. 2010, 40:671-676.
49. Weih F., Caamaño J. Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway. Immunol. Rev. 2003, 195:91-105.
50. Zeng H., Chen Y., Yu M., Xue L., Gao X., Morris S.W., Wang D., Wen R. T cell receptor-mediated activation of CD4+CD44hi T cells bypasses Bcl10: An implication of differential NF-kappaB dependence of naïve and memory T cells during T cell receptor-mediated responses. J. Biol. Chem. 2008, 283:24392-24399.
51. Zheng Y., Vig M., Lyons J., Van Parijs L., Beg A.A. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J. Exp. Med. 2003, 197:861-874.
52. Zheng Y., Josefowicz S., Chaudhry A., Peng X.P., Forbush K., Rudensky A.Y. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.